Upper CBD intake levels ranging from 70 mg to 160 mg per day for dietary supplements are acceptable and do not harm the liver, says a new scientific review commissioned by Canopy Growth Corporation and Charlotte’s Web.
During August, the industry was inspired by reports on consumer trends, welcomed a next step in probiotic harmonisation, discovered further AI technology advances, and encountered regulatory clarity issues.
The founder of the CBD consortium, the ACI (the Association for the Cannabinoid Industry), is putting the pressure on the UK Home Office in a bid to bring some legal clarity and ultimately closure to the seemingly halted CBD Novel Foods process.
The Association for the Cannabinoid Industry (ACI) and the Centre for Medicinal Cannabis (CMC) have formed a strategic partnership with Chem ID Ltd, a provider of chemical data standardisation, validation, and traceability solutions.
Following an increasing popularity and a heightened influx of brands promoting the CBD and coffee pairing, touting an ability to reduce side effects associated with caffeine, a regulatory expert has warned the research backing the benefits is inconclusive.
Ashley Heeley, director and founder of the health and wellness supplements company Hippie Herbal Turtle Co, explains the brand's uniquely wide consumer range due to a heightened demand for convenient natural alternatives to pharmaceuticals.
A cognitive health innovation panel hosted at the Positive Nutrition summit last week (March 30th), discussed key consumer demands in a crowded market, legislation challenges, and the future potential for the space.
A broad-spectrum medicinal cannabis oil is effective in significantly improving sleep quality and duration, midnight melatonin levels, as well as quality of life and mood within two weeks, in adults with insomnia, according to new research.
After five-weeks of CBD administration to hypertensive patients, reductions in blood pressure were paired with significant drops in the catestatin peptides involved in hypertension pathophysiology, a randomised controlled trial observes.
With more than 400 products recently being removed from the FSA’s public list of CBD novel food applications, the retail market should be in the midst of major change, but what should be happening and what is happening are two different discussions in...
The number of sports and active nutrition companies investing in CBD has grown significantly in Europe over the last few years despite regulatory uncertainty, so what does this market hold for these brands? In this article, ESSNA’s Chair Dr Adam Carey,...
Cannabidiol (CBD) shows strong potential for its inclusion in clinical treatment of traumatic brain injuries (TBI), with mechanisms of action including the mediation of the cellular and biochemical changes associated with the injuries, a recent literature...
Najla Guthrie, president and CEO, KGK Science Inc. has been hailed as a global leader and sought-after spokesperson in the nutraceutical trade. She is also a lobbyist for the advancement of policy changes in the supplement and cannabis industries.
The NutraIngredients Awards are back for 2023 with new categories but the same commitment to honour the best and brightest in ingredients, finished products, companies, people, and initiatives in the dietary supplements industry.
Over the course of the next year, lawmakers on the US House and Senate agriculture committees will draft a new federal Farm Bill that will shape a number of programs for the next five years. What does that mean for the hemp industry?
After dominating the UK CBD space with help from a highly engaged online fanbase, CBD beverage, oil and gummy brand Trip is hoping to cement a similar position in the US – but this time with the additional aid of $12m in funding from prominent entrepreneurs...
A new study that sampled dozens of commercially available CBD products found detectable THC levels in 64% of them. Some levels were high enough to approach therapeutic thresholds or to potentially trigger drug test failures.
Proposals to overhaul the UK Cannabidiol (CBD) approval system has led to tension among some members of the Secretariat Advisory Board (SAB) of the All-Party Parliamentary Group (APPG) that liaises with government to inform industry policies.
Last week’s meeting of the U.S. Food and Drug Administration’s Science Board did little to assuage a frustrated CBD industry that continues to call for regulation of the cannabinoid as a dietary supplement.
EFSA’s decision this week to stop the clock on 150 CBD (cannabidiol) Novel Food applications and publish a litany of ‘data gaps’ does not threaten thousands of on-market CBD products in the UK, its Food Standards Agency (FSA) has told NutraIngredients.
The European Food Safety Authority (EFSA) has issued a wide-ranging opinion calling for more safety data for CBD products that could challenge the Novel Foods status of many offerings in the nascent category across the bloc and beyond.
As the stigma surrounding cannabinoids fades, hemp-derived supplements are gaining traction as popular applications for pain management. New research from the University of Arizona Health Sciences in the Comprehensive Pain and Addiction Center have found...
While working at her father’s cigar company, Paola Fernandez invented a ‘natural’ alternative to tobacco-based rolling paper. In 2016, High Hemp was born and sells its flagship hemp wraps along with CBD gummies and tinctures. In under 5 years, Fernandez...
FDA came down hard on purveyors of Delta-8 THC and CBD products that were making disease claims on the substances. The Agency also reiterated the reasons it believes Delta-8 is not a suitable ingredient for products marketed as supplements.